The Novo Nordisk Foundation has established an advisory panel of leading Danish and International experts named the Humanitarian and Development Aid Advisory Panel (HUMDAP).

The panel’s purpose is to advise the foundation about humanitarian and development aid initiatives, including grants, partnerships and strategies, thereby strengthening the implementation of the foundation’s strategy and programs in this area.

In 2019, the foundation launched a new humanitarian and development aid strategy with two specific focus areas: To enhance the prospects of young refuges and other vulnerable youth in the areas and countries affected by the Syrian crisis. And secondly, combating Non-Communicable Diseases in the previous mentioned regions as well as East Africa.

The advisory panel has a diverse membership of both Danish and international experts with many years of experience, strong international networks and deep knowledge within their respective field, including public health, sustainability and human rights as well as insight from the local contexts.

The Humanitarian and Development Aid Advisory Panel was established in 2020 and consists of five external members. Lars Much participates as representative of the Novo Nordisk Foundation’s Board of Directors and Hanne Line Jakobsen, Senior Vice President, chairs the Panel.

Externalt members of the panel:

Kenneth Roth,

CEO, Human Rights Watch

Member since 2020

Bassem Saad,

CEO, Queen Rania Foundation, Jordan

Member since 2020

Lise Kingo,

Former CEO and Executive Director, UN Global Compact

Member since 2020

Wietse Anton Tol,

Professor, Global Health Section, Copenhagen University

Member since 2022

Lotte Machon,

State Secretary for Development Policy, Ministry of Foreign Affairs of Denmark

Member since 2021

For further information contact Tine Welzel on [email protected]